Morphic Holding Inc (NASDAQ:MORF)
| 30.99 Delayed Data As of 3:59pm ET |  -0.70 / -2.21%Today’s Change | 19.23 Today|||52-Week Range 68.75 | -34.59% Year-to-Date |
Institutional investors purchased a net $2.4 million shares of MORF during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 69.46% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Other institutional | 35.80% |
| Mutual fund holders | 33.65% |
| Individual stakeholders | 28.44% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 6/30/2022 | SILVERARC CAPITAL MANAGEMENT LLC Bought 350.0 Thousand shares of Morphic Holding Inc |
| 6/30/2022 | ASSENAGON ASSET MANAGEMENT SA (G... Bought 254.1 Thousand shares of Morphic Holding Inc |
| 6/30/2022 | CANDRIAM BELGIUM SA Bought 160.5 Thousand shares of Morphic Holding Inc |
Top 10 Owners of Morphic Holding Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Fidelity Management & Research Co... | 14.54% | 5,565,161 | 120,763,994 | +21,272 | +0.38% |
| Ecor1 Capital LLC | 10.33% | 3,951,566 | 85,748,982 | 0 | 0.00% |
| Invus Public Equities Advisors LL... | 4.31% | 1,650,000 | 35,805,000 | +64,951 | +4.10% |
| BlackRock Fund Advisors | 3.85% | 1,473,054 | 31,965,272 | +40,822 | +2.85% |
| SSgA Funds Management, Inc. | 3.14% | 1,201,017 | 26,062,069 | +227,635 | +23.39% |
| The Vanguard Group, Inc. | 3.09% | 1,183,950 | 25,691,715 | +45,240 | +3.97% |
| T. Rowe Price Associates, Inc. (I... | 2.91% | 1,112,651 | 24,144,527 | -33,710 | -2.94% |
| Holocene Advisors, LP | 2.04% | 781,742 | 16,963,801 | +447,177 | +133.66% |
| Perceptive Advisors LLC | 2.01% | 767,327 | 16,650,996 | -69,194 | -8.27% |
| Federated Global Investment Manag... | 1.65% | 630,200 | 13,675,340 | +330,200 | +110.07% |
Top 10 Mutual Funds Holding Morphic Holding Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| SPDR S&P Biotech ETF | 3.98% | 1,523,406 | 33,057,910 | -36,168 | -2.32% |
| Fidelity Growth Company Fund | 2.98% | 1,138,647 | 24,708,640 | +75,927 | +7.14% |
| Fidelity Select Port. - Biotechno... | 2.10% | 805,337 | 17,475,813 | 0 | 0.00% |
| Vanguard Total Stock Market Index... | 1.91% | 731,406 | 15,871,510 | +67,135 | +10.11% |
| T Rowe Price New Horizons Fund | 1.53% | 586,526 | 12,727,614 | +106,588 | +22.21% |
| iShares Russell 2000 ETF | 1.49% | 568,655 | 12,339,814 | -570 | -0.10% |
| Federated Hermes Kaufmann Small C... | 1.11% | 425,000 | 9,222,500 | 0 | 0.00% |
| Fidelity Small Cap Growth Fund | 0.97% | 371,306 | 8,057,340 | 0 | 0.00% |
| Fidelity Series Small Cap Opportu... | 0.96% | 367,662 | 7,978,265 | 0 | 0.00% |
| Vanguard Extended Market Index Fu... | 0.93% | 355,303 | 7,710,075 | +5,442 | +1.56% |